Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Three Formulations of the Dermal Implant ELAPR

This study has been completed.
Information provided by (Responsible Party):
Elastagen Pty Ltd Identifier:
First received: March 22, 2011
Last updated: November 7, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)